{"id":"https://openalex.org/W3014612640","doi":"https://doi.org/10.1038/s41375-020-0805-1","title":"Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study","display_name":"Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study","publication_year":2020,"publication_date":"2020-04-07","ids":{"openalex":"https://openalex.org/W3014612640","doi":"https://doi.org/10.1038/s41375-020-0805-1","mag":"3014612640","pmid":"https://pubmed.ncbi.nlm.nih.gov/32265500","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7387297"},"language":"en","primary_location":{"id":"doi:10.1038/s41375-020-0805-1","doi":"https://doi.org/10.1038/s41375-020-0805-1","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41375-020-0805-1","pdf_url":"https://www.nature.com/articles/s41375-020-0805-1.pdf","source":{"id":"https://openalex.org/S149476849","display_name":"Leukemia","issn_l":"0887-6924","issn":["0887-6924","1476-5551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/s41375-020-0805-1.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015101485","display_name":"J\u00f6rge E. Cortes","orcid":"https://orcid.org/0000-0002-8636-1071","observed_orcids":["https://orcid.org/0000-0002-8636-1071"]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jorge E. Cortes","raw_affiliation_strings":["Georgia Cancer Center, Augusta University, Augusta, GA, USA. jorge.cortes@augusta.edu","Georgia Cancer Center, Augusta University, Augusta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Cancer Center, Augusta University, Augusta, GA, USA. jorge.cortes@augusta.edu","institution_ids":["https://openalex.org/I25041050"]},{"raw_affiliation_string":"Georgia Cancer Center, Augusta University, Augusta, GA, USA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100707352","display_name":"Qian Jiang","orcid":"https://orcid.org/0000-0001-7131-0522","observed_orcids":["https://orcid.org/0000-0001-7131-0522","https://orcid.org/0009-0004-8456-7166"]},"institutions":[{"id":"https://openalex.org/I4210124809","display_name":"Peking University People's Hospital","ror":"https://ror.org/035adwg89","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210124809"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qian Jiang","raw_affiliation_strings":["Peking University People's Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peking University People's Hospital, Beijing, China","institution_ids":["https://openalex.org/I4210124809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086214965","display_name":"Jianxiang Wang","orcid":"https://orcid.org/0000-0001-9437-9151","observed_orcids":["https://orcid.org/0000-0001-9437-9151"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]},{"id":"https://openalex.org/I4210147887","display_name":"Institute of Hematology & Blood Diseases Hospital","ror":"https://ror.org/04n16t016","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210147887"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jianxiang Wang","raw_affiliation_strings":["Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China"],"raw_orcid":"https://orcid.org/0000-0001-9437-9151","affiliations":[{"raw_affiliation_string":"Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China","institution_ids":["https://openalex.org/I200296433","https://openalex.org/I4210147887"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036634103","display_name":"Jianyu Weng","orcid":"https://orcid.org/0000-0001-5446-292X","observed_orcids":["https://orcid.org/0000-0001-5446-292X"]},"institutions":[{"id":"https://openalex.org/I4210145693","display_name":"Guangdong Academy of Medical Sciences","ror":"https://ror.org/0432p8t34","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210145693"]},{"id":"https://openalex.org/I4210153930","display_name":"Guangdong Provincial People's Hospital","ror":"https://ror.org/045kpgw45","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153930"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jianyu Weng","raw_affiliation_strings":["Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China","institution_ids":["https://openalex.org/I4210145693","https://openalex.org/I4210153930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072458792","display_name":"Huanling Zhu","orcid":"https://orcid.org/0000-0002-5226-3828","observed_orcids":["https://orcid.org/0000-0002-5226-3828"]},"institutions":[{"id":"https://openalex.org/I4210089761","display_name":"West China Hospital of Sichuan University","ror":"https://ror.org/007mrxy13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210089761"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huanling Zhu","raw_affiliation_strings":["West China Hospital of Sichuan University, Chengdu, Sichuan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"West China Hospital of Sichuan University, Chengdu, Sichuan, China","institution_ids":["https://openalex.org/I4210089761"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100386598","display_name":"Xiaoli Liu","orcid":"https://orcid.org/0000-0003-1686-3292","observed_orcids":["https://orcid.org/0000-0003-1686-3292"]},"institutions":[{"id":"https://openalex.org/I4210103346","display_name":"Nanfang Hospital","ror":"https://ror.org/01eq10738","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103346"]},{"id":"https://openalex.org/I58200834","display_name":"Southern Medical University","ror":"https://ror.org/01vjw4z39","country_code":"CN","type":"education","lineage":["https://openalex.org/I58200834"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaoli Liu","raw_affiliation_strings":["Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China","institution_ids":["https://openalex.org/I4210103346","https://openalex.org/I58200834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035964802","display_name":"Andreas Hochhaus","orcid":"https://orcid.org/0000-0003-0626-0834","observed_orcids":["https://orcid.org/0000-0003-0626-0834"]},"institutions":[{"id":"https://openalex.org/I4210134900","display_name":"Jena University Hospital","ror":"https://ror.org/035rzkx15","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210134900"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Hochhaus","raw_affiliation_strings":["Universit\u00e4tsklinikum Jena, Jena, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e4tsklinikum Jena, Jena, Germany","institution_ids":["https://openalex.org/I4210134900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100359374","display_name":"Dong\u2010Wook Kim","orcid":"https://orcid.org/0000-0003-3967-4267","observed_orcids":["https://orcid.org/0000-0003-3967-4267"]},"institutions":[{"id":"https://openalex.org/I87111246","display_name":"Catholic University of Korea","ror":"https://ror.org/01fpnj063","country_code":"KR","type":"education","lineage":["https://openalex.org/I87111246"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Dong-Wook Kim","raw_affiliation_strings":["The Catholic University of Korea, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Catholic University of Korea, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I87111246"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089541690","display_name":"Jerald P. Radich","orcid":"https://orcid.org/0000-0002-1618-230X","observed_orcids":["https://orcid.org/0000-0002-1618-230X"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jerald Radich","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049400849","display_name":"Michael Robert Savona","orcid":"https://orcid.org/0000-0003-3763-5504","observed_orcids":["https://orcid.org/0000-0003-3763-5504"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Savona","raw_affiliation_strings":["Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034612965","display_name":"Patricia Martin\u2010Regueira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia Martin-Regueira","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112842421","display_name":"Oumar Sy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oumar Sy","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082474691","display_name":"Renuka Gurnani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renuka Gurnani","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019949455","display_name":"Giuseppe Nicola Saglio","orcid":"https://orcid.org/0000-0002-1046-3514","observed_orcids":["https://orcid.org/0000-0002-1046-3514"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Saglio","raw_affiliation_strings":["University of Turin, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":16,"corresponding_author_ids":["https://openalex.org/A5015101485"],"corresponding_institution_ids":["https://openalex.org/I25041050"],"apc_list":{"value":4480,"currency":"USD","value_usd":4480},"apc_paid":{"value":4480,"currency":"USD","value_usd":4480},"fwci":5.2088,"has_fulltext":true,"cited_by_count":56,"citation_normalized_percentile":{"value":0.96557831,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"34","issue":"8","first_page":"2064","last_page":"2073"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9380000233650208},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":1.0},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9779999852180481},{"id":"https://openalex.org/keywords/chronic-phase","display_name":"chronic phase","score":0.9369999766349792},{"id":"https://openalex.org/keywords/suboptimal-response","display_name":"suboptimal response","score":0.5680000185966492},{"id":"https://openalex.org/keywords/major-molecular-response","display_name":"major molecular response","score":0.9390000104904175},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6259999871253967},{"id":"https://openalex.org/keywords/treatment-crossover","display_name":"treatment crossover","score":0.6970000267028809},{"id":"https://openalex.org/keywords/bcr-abl-tyrosine-kinase-inhibitors","display_name":"BCR-ABL tyrosine kinase inhibitors","score":0.6919999718666077}],"concepts":[{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.9573631286621094},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.9313727617263794},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.804567277431488},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7352924346923828},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6299160122871399},{"id":"https://openalex.org/C2993416501","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myeloid leukaemia","level":2,"score":0.6209264993667603},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.555942177772522},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5309683084487915},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4865792989730835},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.41693830490112305}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000069439","descriptor_name":"Dasatinib","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000069439","descriptor_name":"Dasatinib","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015466","descriptor_name":"Leukemia, Myeloid, Chronic-Phase","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015466","descriptor_name":"Leukemia, Myeloid, Chronic-Phase","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1038/s41375-020-0805-1","doi":"https://doi.org/10.1038/s41375-020-0805-1","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41375-020-0805-1","pdf_url":"https://www.nature.com/articles/s41375-020-0805-1.pdf","source":{"id":"https://openalex.org/S149476849","display_name":"Leukemia","issn_l":"0887-6924","issn":["0887-6924","1476-5551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7387297","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7387297","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"Text"},{"id":"pmid:32265500","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32265500","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"Comparative Study"},{"id":"pmh:oai:zenodo.org:26527","doi":null,"is_oa":true,"landing_page_url":"https://www.openaccessrepository.it/record/26527","pdf_url":null,"source":{"id":"https://openalex.org/S4306402478","display_name":"INFM-OAR (INFN Catania)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210116497","host_organization_name":"Istituto Nazionale di Fisica Nucleare, Sezione di Catania","host_organization_lineage":["https://openalex.org/I4210116497"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1038/s41375-020-0805-1","doi":"https://doi.org/10.1038/s41375-020-0805-1","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41375-020-0805-1","pdf_url":"https://www.nature.com/articles/s41375-020-0805-1.pdf","source":{"id":"https://openalex.org/S149476849","display_name":"Leukemia","issn_l":"0887-6924","issn":["0887-6924","1476-5551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3014612640.pdf","grobid_xml":"https://content.openalex.org/works/W3014612640.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1580788756","https://openalex.org/W1968747503","https://openalex.org/W1979300931","https://openalex.org/W1980571402","https://openalex.org/W1986635169","https://openalex.org/W1987060661","https://openalex.org/W1999130958","https://openalex.org/W2009972868","https://openalex.org/W2011474502","https://openalex.org/W2022158208","https://openalex.org/W2031330193","https://openalex.org/W2034469570","https://openalex.org/W2038981426","https://openalex.org/W2057206328","https://openalex.org/W2091005492","https://openalex.org/W2097799776","https://openalex.org/W2105783133","https://openalex.org/W2106392592","https://openalex.org/W2330813625","https://openalex.org/W2330814896","https://openalex.org/W2397234997","https://openalex.org/W2556518969","https://openalex.org/W2591297419","https://openalex.org/W2793625425","https://openalex.org/W2886320425","https://openalex.org/W2887711883","https://openalex.org/W3147894994","https://openalex.org/W4293241248"],"related_works":["https://openalex.org/W4396596325","https://openalex.org/W4310106628","https://openalex.org/W2904392588","https://openalex.org/W2949269851","https://openalex.org/W2058216377","https://openalex.org/W960978438","https://openalex.org/W2618548116","https://openalex.org/W7145396444","https://openalex.org/W2566861500","https://openalex.org/W2244247831"],"abstract_inverted_index":{"Early":[0],"molecular":[1,10,86],"response":[2,11,50,87,179],"is":[3,186],"associated":[4],"with":[5,17,48,56,129,133,145,166],"improved":[6],"probability":[7],"of":[8,41,84,105,150,155,163,177,194],"deep":[9],"and":[12,96,131,136,169],"superior":[13],"survival":[14],"in":[15,21,46,175],"patients":[16,23,47,55,108,164],"CML-CP.":[18],"However,":[19],"~1":[20],"3":[22],"on":[24],"first-line":[25,52,167],"imatinib":[26,71,113,134],"do":[27],"not":[28],"achieve":[29],"this":[30,156],"threshold.":[31],"The":[32,78,153],"phase":[33],"2b":[34],"DASCERN":[35],"trial":[36],"(NCT01593254)":[37],"assessed":[38],"the":[39,82,122,146,190],"outcome":[40],"early":[42,161,195],"switch":[43],"to":[44,51,61,111,117,173,188],"dasatinib":[45,65,130,174],"suboptimal":[49,178],"imatinib.":[53],"Adult":[54],"CML-CP":[57],"were":[58,143],"randomized":[59,110],"(2:1)":[60],"receive":[62],"100":[63],"mg":[64,74],"(n":[66,75],"=":[67,76,100],"174)":[68],"or":[69],"continue":[70,112],"at":[72,89],"\u2265400":[73],"86).":[77],"primary":[79],"endpoint":[80],"was":[81,93,127],"rate":[83,126],"major":[85],"(MMR)":[88],"12":[90],"months,":[91],"which":[92],"29%":[94],"(dasatinib)":[95],"13%":[97],"(imatinib;":[98],"P":[99],"0.005).":[101],"After":[102],"\u22652":[103],"years":[104],"follow-up,":[106],"45":[107],"(52%)":[109],"had":[114],"crossed":[115],"over":[116],"dasatinib.":[118],"Considering":[119],"treatment":[120],"crossover,":[121],"2-year":[123],"cumulative":[124],"MMR":[125],"64%":[128],"41%":[132],"(66%":[135],"67%,":[137],"respectively":[138],"by":[139],"intent-to-treat).":[140],"Adverse":[141],"events":[142],"consistent":[144],"established":[147],"safety":[148],"profiles":[149],"both":[151],"drugs.":[152],"results":[154],"first":[157],"prospective":[158],"study":[159],"support":[160],"monitoring":[162],"treated":[165],"imatinib,":[168],"suggest":[170],"that":[171],"switching":[172],"cases":[176],"may":[180],"offer":[181],"clinical":[182,192],"benefit.":[183],"Further":[184],"follow-up":[185],"needed":[187],"assess":[189],"long-term":[191],"benefit":[193],"switching.":[196]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-04-10T00:00:00"}